News

On May 15, the Democratic Republic of the Congo (DRC) declared its 17th Ebola virus disease outbreak, caused by the Bundibugyo virus, for which there ...

Despite its proven effectiveness, hydroxyurea remains difficult to access and underused in sub-Saharan Africa. Two studies conducted by Epicentre and ...

On May 15, 2026, the Democratic Republic of Congo's Ministry of Health officially declared an Ebola disease outbreak in the northeast of the country, ...

In Pakistan, Epicentre is conducting a study to better understand how new, all oral, shorter treatments for multidrug-resistant/rifampicin‑resistant t...

The AMoCo* study continues to highlight persistent challenges related to abortion care and complications in fragile and conflict-affected settings. Co...

With cholera epidemics on the rise and global vaccine stocks remaining under pressure, in 2024 the WHO prequalified a new oral cholera vaccine, Euvich...

At the World Conference on Lung Health held from November 18 to 21, 2025, in Copenhagen, Médecins Sans Frontières (MSF) and Epicentre have revealed th...

To gain a better understanding of the issues at stake in terms of HIV prevention and action, Jihane Ben-Farhat has carried out an in-depth analysis of...

In Mali, breast and cervical cancer account for nearly half of all cancers in women, with a very high mortality rate of 60% (1). Faced with this burde...

In some regions of Kenya, more than one person in five is now affected by hypertension (1). However, treatment is still too limited, despite the intro...